What Happened?
Radnor, PA-based Complexa-Inc Appointed Joshua Tarnoff as Director, President and Chief Executive Officer
About the Company
Complexa is a clinical stage biopharmaceutical company focused on transforming the treatment of fibrosis and inflammation-associated orphan diseases. Leveraging its differentiated endogenous nitrated fatty acid cell signaling technology, Complexa is advancing a platform of agents which target fibrosis and inflammation across multiple orphan disease indications.
About the Person
Joshua Tarnoff is Director, President and Chief Executive Officer at Complexa Inc. Previously, Joshua held various senior HR leadership roles in the industry.
Info Source
News
Short Profile